Filters close
13-Nov-2001 12:00 AM EST
Bupropion SR Effective in Treating Neuropathic Pain
American Academy of Neurology (AAN)

Patients with neuropathic pain found greater relief, and fewer side effects, when treated with bupropion SR (sustained-release) than with commonly prescribed treatments. These findings came from a study conducted at the University of Arizona Neurology Clinic and Pain Clinic in Tucson.

13-Nov-2001 12:00 AM EST
Hepatitis E Recovered from Rats in Los Angeles
American Society for Microbiology (ASM)

Researchers from the National Institutes of Health have recovered a virus similar to the hepatitis E virus (HEV) from rats in Los Angeles, California, a finding that may explain high levels of HEV exposure in inner-city residents without disease. They report their findings at the 50th Annual Meeting of the American Society of Tropical Medicine and Hygiene.

13-Nov-2001 12:00 AM EST
Antibodies to Liver Stage Associated with Malaria Resistance
American Society for Microbiology (ASM)

High levels of antibodies against the liver stage of the malaria parasite appear to predict resistance to the disease say researchers from Brown University and the Seattle Biomedical Research Institute. These findings, presented at the 50th Annual Meeting of the American Society of Tropical Medicine and Hygiene, could eventually lead to new strategies for malaria vaccines or treatments.

13-Nov-2001 12:00 AM EST
EECP Therapy May Generate a New Blood Supply in the Diseased Heart
de Richemond Advisors

New research presented at the American Heart Association's Scientific Sessions 2001 conference provides further evidence that EECP therapy stimulates the release of angiogenic factors, and offers hope of noninvasive treatment based on rejuvenating circulation in the diseased heart.

13-Nov-2001 12:00 AM EST
Positive Attitude Is Best Prevention Against Heart Disease
Johns Hopkins Medicine

A positive outlook may offer the strongest known protection against heart disease in adults at risk, according to a Johns Hopkins study. The report, which looked at nearly 600 adults with a family history of heart disease, will be presented Nov. 12 at the American Heart Association's annual Scientific Sessions in Anaheim, Calif.

12-Nov-2001 12:00 AM EST
Treatment for Connective Tissue Disease-Associated Heart and Lung Problems
American College of Rheumatology (ACR)

Treprostinil, a structural analogue of naturally occurring prostacyclin, has been shown to be safe and effective in the treatment of patients with pulmonary hypertension associated with various forms of connective tissue disease.

12-Nov-2001 12:00 AM EST
Tai Chi May Help People with Osteoarthritis
American College of Rheumatology (ACR)

A Tai Chi exercise program may result in less pain and fewer difficulties with daily activities, according to research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 10 - 15 in San Francisco, California.

12-Nov-2001 12:00 AM EST
RA Sufferers: Early Treatment May Mean Better Quality of Life
American College of Rheumatology (ACR)

Treating rheumatoid arthritis early on is the key to better outcomes and decreased disability, according to several sets of research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 10 - 15 in San Francisco, California.

12-Nov-2001 12:00 AM EST
Unlike Aspirin, NSAIDS May Not Reduce the Risk of Heart Attacks
American College of Rheumatology (ACR)

It appears that most of the aspirin-type medications referred to as NSAIDs do not decrease the risk of heart attacks with the exception of one, according to research presented at the American College of Rheumatology Annual Scientific Meeting in San Francisco, California.

12-Nov-2001 12:00 AM EST
New Therapies for the Treatment of Rheumatoid Arthritis
American College of Rheumatology (ACR)

Two investigational therapies show promise in treating rheumatoid arthritis, according to research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 10 - 15 in San Francisco, California.

12-Nov-2001 12:00 AM EST
A Potential New Drug Therapy for Rheumatoid Arthritis Sufferers
American College of Rheumatology (ACR)

CDP870, a potential new anti-TNF therapy, shows promising results in the treatment of rheumatoid arthritis, according to research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 10 - 15 in San Francisco, California.

12-Nov-2001 12:00 AM EST
Skip the Decaf Coffee and Have a Cup of Tea Instead
American College of Rheumatology (ACR)

Drinking decaffeinated coffee may increase your risk developing rheumatoid arthritis if you're an older woman, according to research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 10 - 15 in San Francisco, California.

12-Nov-2001 12:00 AM EST
A New Option for Treating Ankylosing Spondylitis
American College of Rheumatology (ACR)

People with ankylosing spondylitis who are treated with etanercept, an anti TNF therapy which has been used to treat rheumatoid arthritis, may experience significant improvement in pain and mobility.

12-Nov-2001 12:00 AM EST
Treatment for Rheumatoid Arthritis Sufferers
American College of Rheumatology (ACR)

People with rheumatoid arthritis who are already taking methotrexate may have further improvement in arthritis control with the addition of a new injectable treatment called adalimumab, according to research presented at the ACR Annual Scientific Meeting.

12-Nov-2001 12:00 AM EST
Another Option for Patients with Moderate to Severe Rheumatoid Arthritis
American College of Rheumatology (ACR)

People with rheumatoid arthritis who take methotrexate but continue to have active arthritis may have further improvement in arthritis control with the addition of a new injectable treatment called anakinra.

12-Nov-2001 12:00 AM EST
New Arthritis Drugs
University of Alabama at Birmingham

A multi-center, international pilot study of two new drugs to treat patients with rheumatoid arthritis has found the drugs to be safe and effective in treating the disease.

12-Nov-2001 12:00 AM EST
Decaf Coffee Increases Risk of RA
University of Alabama at Birmingham

Older women who drink four or more cups of decaffeinated coffee a day are more than twice as likely to develop rheumatoid arthritis, while women who drink more than three cups of tea a day are much less likely to develop the disease, according to a recent UAB study.

Released: 10-Nov-2001 12:00 AM EST
Round Two of Gender-Bending Salmon: The Mystery Expands
University of Idaho

A University of Idaho zoologist is sampling more chinook salmon from Northwest rivers this fall in hope of solving a mystery: are some female chinook really gender bending males? New samples indicate the mystery pervades the Columbia Basin.

Released: 10-Nov-2001 12:00 AM EST
NSF Awards Two Plant Genome Grants to University of Minnesota
University of Minnesota

Two groups of plant scientists at the University of Minnesota have each received four-year, $3.1M grants from the National Science Foundation to study the genomes of legumes and corn as part of NSF's Plant Genome Research Program.

Released: 10-Nov-2001 12:00 AM EST
Decontamination Treatment for Anthrax
University of Missouri

In response to the immediate threats of bio-terrorist attacks, two University of Missouri-Columbia College of Engineering researchers have developed a process that rapidly kills a wide range of microbes on any surface, including anthrax spores and viruses.



close
4.83177